Advanced Proteome Therapeutics Corp (APTCF) Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
Advanced Proteome Therapeutics Corp operates in the biotechnology research sector, focusing on therapeutics discovery and development. Its work centers on antibody-drug conjugates, aiming to deliver targeted therapies through antibody-based delivery of cytotoxic agents. In 2018 the company disclosed a collaboration and option agreement with ImmunoBiochem to develop superior antibody-drug conjugates. The company is based in Boston, Massachusetts, and is described as a small biotechnology team. Publicly documented activity from 2017 to 2018 includes executive and board appointments as well as collaborations with external research organizations such as the National Research Council of Canada and ImmunoBiochem. These partnerships suggest a strategy of pursuing joint development efforts with partner organizations to advance antibody-drug conjugate therapeutics.